Copyright Reports & Markets. All rights reserved.

Global Enterovirus Vaccine Market Research Report 2021

Request for Sample of this report
Buy now

1 Enterovirus Vaccine Market Overview

  • 1.1 Product Overview and Scope of Enterovirus Vaccine
  • 1.2 Enterovirus Vaccine Segment by Type
    • 1.2.1 Global Enterovirus Vaccine Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 Coxasckievirus A
    • 1.2.3 Coxasckievirus B
    • 1.2.4 Human Enterovirus 71
    • 1.2.5 Others
  • 1.3 Enterovirus Vaccine Segment by Application
    • 1.3.1 Global Enterovirus Vaccine Sales Comparison by Application: (2021-2027)
    • 1.3.2 Hospital
    • 1.3.3 Research Institute
    • 1.3.4 Others
  • 1.4 Global Enterovirus Vaccine Market Size Estimates and Forecasts
    • 1.4.1 Global Enterovirus Vaccine Revenue 2016-2027
    • 1.4.2 Global Enterovirus Vaccine Sales 2016-2027
    • 1.4.3 Enterovirus Vaccine Market Size by Region: 2016 Versus 2021 Versus 2027

2 Enterovirus Vaccine Market Competition by Manufacturers

  • 2.1 Global Enterovirus Vaccine Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global Enterovirus Vaccine Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global Enterovirus Vaccine Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers Enterovirus Vaccine Manufacturing Sites, Area Served, Product Type
  • 2.5 Enterovirus Vaccine Market Competitive Situation and Trends
    • 2.5.1 Enterovirus Vaccine Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest Enterovirus Vaccine Players Market Share by Revenue
    • 2.5.3 Global Enterovirus Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Enterovirus Vaccine Retrospective Market Scenario by Region

  • 3.1 Global Enterovirus Vaccine Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.2 Global Enterovirus Vaccine Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.3 North America Enterovirus Vaccine Market Facts & Figures by Country
    • 3.3.1 North America Enterovirus Vaccine Sales by Country
    • 3.3.2 North America Enterovirus Vaccine Revenue by Country
    • 3.3.3 United States
    • 3.3.4 Canada
  • 3.4 Europe Enterovirus Vaccine Market Facts & Figures by Country
    • 3.4.1 Europe Enterovirus Vaccine Sales by Country
    • 3.4.2 Europe Enterovirus Vaccine Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Enterovirus Vaccine Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Enterovirus Vaccine Sales by Region
    • 3.5.2 Asia Pacific Enterovirus Vaccine Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
  • 3.6 Latin America Enterovirus Vaccine Market Facts & Figures by Country
    • 3.6.1 Latin America Enterovirus Vaccine Sales by Country
    • 3.6.2 Latin America Enterovirus Vaccine Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
    • 3.6.6 Colombia
  • 3.7 Middle East and Africa Enterovirus Vaccine Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Enterovirus Vaccine Sales by Country
    • 3.7.2 Middle East and Africa Enterovirus Vaccine Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 UAE

4 Global Enterovirus Vaccine Historic Market Analysis by Type

  • 4.1 Global Enterovirus Vaccine Sales Market Share by Type (2016-2021)
  • 4.2 Global Enterovirus Vaccine Revenue Market Share by Type (2016-2021)
  • 4.3 Global Enterovirus Vaccine Price by Type (2016-2021)

5 Global Enterovirus Vaccine Historic Market Analysis by Application

  • 5.1 Global Enterovirus Vaccine Sales Market Share by Application (2016-2021)
  • 5.2 Global Enterovirus Vaccine Revenue Market Share by Application (2016-2021)
  • 5.3 Global Enterovirus Vaccine Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 Sinovac Biotech
    • 6.1.1 Sinovac Biotech Corporation Information
    • 6.1.2 Sinovac Biotech Description and Business Overview
    • 6.1.3 Sinovac Biotech Enterovirus Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 Sinovac Biotech Enterovirus Vaccine Product Portfolio
    • 6.1.5 Sinovac Biotech Recent Developments/Updates
  • 6.2 Medigen Vaccine Biologics
    • 6.2.1 Medigen Vaccine Biologics Corporation Information
    • 6.2.2 Medigen Vaccine Biologics Description and Business Overview
    • 6.2.3 Medigen Vaccine Biologics Enterovirus Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 Medigen Vaccine Biologics Enterovirus Vaccine Product Portfolio
    • 6.2.5 Medigen Vaccine Biologics Recent Developments/Updates
  • 6.3 Shenzhen Neptunus
    • 6.3.1 Shenzhen Neptunus Corporation Information
    • 6.3.2 Shenzhen Neptunus Description and Business Overview
    • 6.3.3 Shenzhen Neptunus Enterovirus Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 Shenzhen Neptunus Enterovirus Vaccine Product Portfolio
    • 6.3.5 Shenzhen Neptunus Recent Developments/Updates
  • 6.4 Sinopharm
    • 6.4.1 Sinopharm Corporation Information
    • 6.4.2 Sinopharm Description and Business Overview
    • 6.4.3 Sinopharm Enterovirus Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Sinopharm Enterovirus Vaccine Product Portfolio
    • 6.4.5 Sinopharm Recent Developments/Updates
  • 6.5 Adimmune
    • 6.5.1 Adimmune Corporation Information
    • 6.5.2 Adimmune Description and Business Overview
    • 6.5.3 Adimmune Enterovirus Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 Adimmune Enterovirus Vaccine Product Portfolio
    • 6.5.5 Adimmune Recent Developments/Updates
  • 6.6 Intravacc
    • 6.6.1 Intravacc Corporation Information
    • 6.6.2 Intravacc Description and Business Overview
    • 6.6.3 Intravacc Enterovirus Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 Intravacc Enterovirus Vaccine Product Portfolio
    • 6.6.5 Intravacc Recent Developments/Updates
  • 6.7 Shanghai Zerun Biotechnology
    • 6.6.1 Shanghai Zerun Biotechnology Corporation Information
    • 6.6.2 Shanghai Zerun Biotechnology Description and Business Overview
    • 6.6.3 Shanghai Zerun Biotechnology Enterovirus Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Shanghai Zerun Biotechnology Enterovirus Vaccine Product Portfolio
    • 6.7.5 Shanghai Zerun Biotechnology Recent Developments/Updates
  • 6.8 Beijing Minhai Biotechnology
    • 6.8.1 Beijing Minhai Biotechnology Corporation Information
    • 6.8.2 Beijing Minhai Biotechnology Description and Business Overview
    • 6.8.3 Beijing Minhai Biotechnology Enterovirus Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 6.8.4 Beijing Minhai Biotechnology Enterovirus Vaccine Product Portfolio
    • 6.8.5 Beijing Minhai Biotechnology Recent Developments/Updates

7 Enterovirus Vaccine Manufacturing Cost Analysis

  • 7.1 Enterovirus Vaccine Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Enterovirus Vaccine
  • 7.4 Enterovirus Vaccine Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Enterovirus Vaccine Distributors List
  • 8.3 Enterovirus Vaccine Customers

9 Enterovirus Vaccine Market Dynamics

  • 9.1 Enterovirus Vaccine Industry Trends
  • 9.2 Enterovirus Vaccine Growth Drivers
  • 9.3 Enterovirus Vaccine Market Challenges
  • 9.4 Enterovirus Vaccine Market Restraints

10 Global Market Forecast

  • 10.1 Enterovirus Vaccine Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Enterovirus Vaccine by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of Enterovirus Vaccine by Type (2022-2027)
  • 10.2 Enterovirus Vaccine Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Enterovirus Vaccine by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of Enterovirus Vaccine by Application (2022-2027)
  • 10.3 Enterovirus Vaccine Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Enterovirus Vaccine by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of Enterovirus Vaccine by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    Coxasckievirus A
    Coxasckievirus B
    Human Enterovirus 71
    Others

    Segment by Application
    Hospital
    Research Institute
    Others

    By Region
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Latin America
    Mexico
    Brazil
    Argentina
    Colombia
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    By Company
    Sinovac Biotech
    Medigen Vaccine Biologics
    Shenzhen Neptunus
    Sinopharm
    Adimmune
    Intravacc
    Shanghai Zerun Biotechnology
    Beijing Minhai Biotechnology

    Buy now